tm logo
PRONOVA BIOPHARMA
Dead/Cancelled
CANCELLED – SECTION 71

on 26 Feb 2021

Last Applicant/ Owned by

N-0283 OSLO

NO

Serial Number

79048576 filed on 30th Oct 2007

Registration Number

3543855 registered on 09th Dec 2008

in the Principal Register

Correspondent Address

Wendy E. Miller

Cooper & Dunham LLP

30 Rockefeller Plaza

New York NY 10112

Filing Basis

No Filing Basis

Disclaimer

"BIOPHARMA"

PRONOVA BIOPHARMA

PRONOVA BIO PHARMACEUTICAL Pharmaceutical preparations for use in the treatment of metabolic, inflammatory and cardiovascular diseases; lipids for pharmaceutical purposes for use in the treatment of metabolic, inflammatory and cardiovascular diseases; substances with marine origin, namely, Omega 3 lipids for pharmaceutical purposes used in the treatment of metabolic, inflammatory and cardiovasculRead More

Classification Information


Class [005]
Pharmaceutical Products


Pharmaceutical preparations for use in the treatment of metabolic, inflammatory and cardiovascular diseases; lipids for pharmaceutical purposes for use in the treatment of metabolic, inflammatory and cardiovascular diseases; substances with marine origin, namely, Omega 3 lipids for pharmaceutical purposes used in the treatment of metabolic, inflammatory and cardiovascular diseases

Mark Details


Serial Number

No 79048576

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 7549-85556

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
14th Jan 2022TOTAL INVALIDATION PROCESSED BY THE IB
09th Dec 2021TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
09th Dec 2021INVALIDATION PROCESSED
26th Oct 2021TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
26th Feb 2021CANCELLED SECTION 71
08th Nov 2018CHANGE OF NAME/ADDRESS REC'D FROM IB
09th Dec 2017COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
16th Nov 2017INTERNATIONAL REGISTRATION RENEWED
27th Aug 2015NEW REPRESENTATIVE AT IB RECEIVED
08th Jan 2015NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED